Comparison

Lyrebird vs TeleScribe

Both Australian. Same core job. ~51% price difference. Here's the honest comparison, line by line, with sources.

Built by Clinicians. Kept in Australia. No multinational marketing tax.

FeatureTeleScribeLyrebird Pro
Pro tier, billed monthly (AUD)$79/mo, no annual lock-in$240/mo
Pro tier, billed annually (effective AUD)$79/mo (no annual discount; no lock-in)$160/mo (~$1,920/year, 33% saving)
Free tier14-day full-access trial50 consult notes + 10 documents per month, ongoing
Bp Premier bundleNot applicableYes — “Bp Free” tier free for Bp Premier subscribers
Registrar discount40% off student / registrar rate80% off Pro for the duration of registrar employment
Video consult includedYes — browser-to-browser, no add-onCaptures audio from existing video calls; does not provide its own video platform
Lit search at point of careIncluded (beta) in subscriptionNot advertised on pages reviewed
Best Practice (Bp Premier) integrationPlanned (not yet live)Yes — “Exclusively built into Bp Premier” with field write-back
CCMP / GPMP / MHTP / Health Assessment auto-fillCare plan and mental health note types supported, not a named billing-code workflowYes — Initial 721 / Review 732, MHTP, ATSI / 45-49 / 75+ Health Assessments auto-filled from EMR
Built by clinicians, kept in AustraliaYes — Australian owner, Australian-hosted databaseAustralian company; “processed and stored within Australia”
Owner / ABNBlack Health Intelligence Pty Ltd (ABN 23 693 026 112)Lyrebird Health Pty Ltd (Australian-incorporated)
Number of clinical tools (built-in calculators)13 named validated toolsDASS-21 sent pre-consult for MHTP workflow; others not itemised
MDO / national guidanceNot yetCo-developed national AI scribe guidance with MDA National
All facts verified against publicly available sources on 2026-04-14. TeleScribe makes no claim about features it cannot independently verify on the date shown.

The $972/year difference

Per Lyrebird's public pricing page on 2026-04-14, Lyrebird Pro is $160 AUD/month billed annually — approximately $1,920 per year, paid upfront.

TeleScribe is $79 AUD/month, billed monthly. That's roughly $948 per year if paid every month, with no upfront commitment. The difference is approximately $972 per year per clinician — for two clinicians that's about $1,944, for five it's about $4,860.

Both products do the core job: capture audio, generate clinical notes. TeleScribe additionally includes video consult and lit search (beta) in the subscription, with no add-ons.

We make no claim about features Lyrebird may offer that are not advertised on its public pricing page as of 2026-04-14. Email office@telescribe.com.au if anything here is inaccurate.

Common questions

How much cheaper is TeleScribe than Lyrebird?

TeleScribe is $79 AUD/month. Lyrebird Pro is $160 AUD/month billed annually (~$1,920/year) per Lyrebird’s public pricing page on 2026-04-14. That is approximately a 51% difference per month and approximately $972 per year saved.

Is TeleScribe billed monthly or annually?

TeleScribe is billed monthly at $79 AUD with no annual lock-in. Lyrebird Pro is billed annually (~$1,920 upfront) per its public pricing page on 2026-04-14.

Does TeleScribe include video consult like Lyrebird does?

TeleScribe includes browser-to-browser video consult in every subscription — no per-minute charges, no add-on, no external platform. Lyrebird does not advertise video consult as a core included feature on its homepage as of 2026-04-14.

What about lit search?

TeleScribe includes a lit search beta in every subscription — search evidence at the point of care without leaving the consult. Lyrebird does not advertise lit search as a core included feature as of 2026-04-14.

Are both companies Australian?

Yes. Both Lyrebird and TeleScribe are Australian companies. TeleScribe is owned by Black Health Intelligence Pty Ltd (ABN 23 693 026 112), verifiable on the Australian Business Register.

Save approximately $972/year

14-day free trial. Full feature access. Monthly billing, no annual lock-in.

Start your 14-day free trial